Optimised dosage of diaminophenothiazines in populations
MYPI2025001037A0Undetermined Publication Date: 2020-01-26WISTA LAB LTD
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MYPI2025001037
- Authority / Receiving Office
- MY · MY
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2019-07-01
- Filing Date
- 2019-07-18
- Publication Date
- 2020-01-26
Abstract
The invention provides novel dosing regimens for Leuco-Methylthioninium (LMT) compounds which maximise the proportion of subjects in which the MT concentration will exceed concentrations in which therapeutic efficacy in relation to treatment of neurodegenerative disorders such as Alzheimer’s disease and frontotemporal dementias can be achieved, while maintaining a desirable clinical profile. Also provided are LMT-containing dosage units and other compositions. Fig. 1
Need to check novelty before this filing date? Find Prior Art
